![]()
|
|
||||||||
J. Biol. Chem., Vol. 260, Issue 3, 1811-1820, 02, 1985
M Okada, B Blomback, MD Chang and B Horowitz
Plasma fibronectin is covalently incorporated into alpha-chains of fibrin
gels in the presence of Factor XIII activated by thrombin (FXIIIaT) but not
by Factor XIII activated by the snake venom enzyme batroxobin (FXIIIaB).
FXIIIaB catalyzes introduction of gamma-gamma cross-links in fibrin but
cross-linked alpha-chains are not formed. In the presence of FXIIIaT,
fibrin gels formed by batroxobin incorporated fibronectin and the
alpha-chains are cross-linked indicating that FXIIIaB has a different
substrate specificity from FXIIIaT. In the presence of FXIIIaT the
incorporation of fibronectin approaches 1 mol/340 kDa unit weight of
fibrin. Fibronectin when present in a fibrinogen thrombin mixture
containing FXIII does not influence the clotting time of the system nor the
release of fibrinopeptides. Incorporation of fibronectin is not appreciable
before the gel point. This indicates that the polymerization and gelation
of fibrinogen is essentially not perturbed by the presence of fibronectin
and that fibrin in the gel matrix rather than the fibrin polymers formed
prior to gel point is the preferred structure for fibronectin
incorporation. Incorporation of fibronectin into fibrin gels during
formation leads to an increase in turbidity and a small decrease in Ks
(permeability coefficient). This suggests that the width of the strands in
the gel increases as a result of fibronectin incorporation. Fibronectin is
also incorporated into preformed gels having completely cross-linked gamma-
and alpha-chains perhaps indicating that the sites in fibrin involved in
fibronectin incorporation are different from those involved in fibrin
cross-linking. FXIIIaT appeared to be adsorbed to fibrin gel matrix in the
presence but not in the absence of calcium ions.
Fibronectin and fibrin gel structure
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
E. M. Scott, R. A.S. Ariens, and P. J. Grant Genetic and Environmental Determinants of Fibrin Structure and Function: Relevance to Clinical Disease Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1558 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. S. Ariens, T.-S. Lai, J. W. Weisel, C. S. Greenberg, and P. J. Grant Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms Blood, July 18, 2002; 100(3): 743 - 754. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Corbett and J. E. Schwarzbauer Requirements for alpha 5beta 1 Integrin-mediated Retraction of Fibronectin-Fibrin Matrices J. Biol. Chem., July 23, 1999; 274(30): 20943 - 20948. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Elssner, G. Mazur, and C. Vogelmeier Inhibition of factor XIIIa-mediated incorporation of fibronectin into fibrin by pulmonary surfactant Am J Physiol Lung Cell Mol Physiol, April 1, 1999; 276(4): L625 - L630. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Sierra Fibrin Sealant Adhesive Systems: A Review of Their Chemistry, Material Properties and Clinical Applications J Biomater Appl, January 1, 1993; 7(4): 309 - 352. [Abstract] [PDF] |
||||
![]() |
M. Rabaud, J.Y. Elie, F. Lefebvre, D. Ducassou, P. Mettetal, M. Le Guillou, D. Collet, J. Perissat, D. Fradin, and F. Fontan A New Biodegradable Elastin-Fibrin Material; Its Use in Urological, Digestive and Cardiovascular Surgery J Biomater Appl, January 1, 1992; 7(1): 20 - 46. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |